Biotech · Private company
ForSight Vision5, Inc.
Track this companyFree. Adds ForSight Vision5, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BimatoprostPhase 2 · Primary Open-Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Timolol 0.5%Phase 2 · Primary Open-Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular InsertPHASE2 · COMPLETED · started Aug 10, 2015ClinicalTrials.gov NCT02537015 · fetched Nov 12, 2026
- Dose-Ranging Study of the Bimatoprost Ocular InsertPHASE2 · COMPLETED · started Jan 19, 2015ClinicalTrials.gov NCT02358369 · fetched Nov 12, 2026
- An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 ProductPHASE2 · COMPLETED · started Jun 5, 2014ClinicalTrials.gov NCT02143843 · fetched Nov 12, 2026